Agilent Technologies Presents Early Career Professor Award to Dr. Gary Patti

Washington University in St. Louis Professor Recognized for Groundbreaking Work in Metabolomics SANTA CLARA, Calif., July 10, 2017 Agilent Technologies Inc. (NYSE: A) has named Dr. Gary J. Patti, as the recipient of the prestigious 2017 Agilent Early Career Professor Award. Dr. Patti, Associate Professor, Department of Chemistry in Arts & Sciences, Washington University in... Read more

Sartorius mourns the loss of Arnold Picot

Long-term Supervisory Board Chairman passes away Goettingen, Germany, July 10, 2017 – The Chairman of the Supervisory Board of Sartorius AG, Professor Arnold Picot, Ph.D., died unexpectedly at age 72 on July 9, 2017. Arnold Picot, who as executor also administered Horst Sartorius’ estate, had served at the helm of the Supervisory Board of Sartorius... Read more

Roka Bioscience to Present at the International Association of Food Protection Conference

Roka Bioscience to Present at the International Association of Food Protection Conference WARREN, N.J., July 7, 2017 /PRNewswire/ — Roka Bioscience, Inc. (NASDAQ: ROKA) will be participating and presenting at the 2017 International Association for Food Protection (IAFP) Conference. The conference will be held at the Tampa Convention Center in Tampa, Florida, from July 9th through July... Read more

Invitation to Roche Analyst Event at ISTH 2017

Basel, 07 July 2017 Invitation to Roche Analyst Event at ISTH 2017 Monday, 10 July 2017, 6:30pm CEST Roche will host an analyst briefing during the International Society on Thrombosis and Hemostasis Congress (ISTH) in Berlin 8 – 13 July 2017. Meeting Information Date: Monday, 10 July 2017 Time: 6:00pm Registration desk opens 6:30pm Start... Read more

Agilent Technologies Acquires Raman Spectroscopy Innovator, Cobalt Light Systems

Cobalt’s portfolio of solutions accelerates entry into high-growth Raman spectroscopy market and expands Agilent’s value proposition for pharmaceutical and biopharma customers SANTA CLARA, Calif.–(BUSINESS WIRE)–Jul. 7, 2017– Agilent Technologies Inc. (NYSE:A) today announced it has acquired Oxfordshire, U.K.-based Cobalt Light Systems (“Cobalt”), a provider of highly differentiated Raman spectroscopic instruments for the pharmaceutical industry, applied... Read more

Agilent Technologies Acquires Raman Spectroscopy Innovator, Cobalt Light Systems

Cobalt’s portfolio of solutions accelerates entry into high-growth Raman spectroscopy market and expands Agilent’s value proposition for pharmaceutical and biopharma customers SANTA CLARA, Calif.–(BUSINESS WIRE)–Jul. 7, 2017– Agilent Technologies Inc. (NYSE:A) today announced it has acquired Oxfordshire, U.K.-based Cobalt Light Systems (“Cobalt”), a provider of highly differentiated Raman spectroscopic instruments for the pharmaceutical industry, applied... Read more

MKS Instruments Successfully Completes Third Repricing of Secured Term Loan

Cumulative Actions Since Origination Reduce Annualized Non-GAAP Interest Expense by 45% ANDOVER, Mass., July 06, 2017 (GLOBE NEWSWIRE) — MKS Instruments, Inc. (NASDAQ:MKSI), a global provider of technologies that enable advanced processes and improve productivity, announced today the third successful repricing of its existing secured term loan. The lenders have agreed to an amendment that... Read more

In Memoriam: The Company was deeply saddened to learn of Mr. Chris van Ingen’s passing on June 27, 2017.

Mr. van Ingen served on the Company’s Board from 2012 to June 2017, and as a director of Bruker Energy & Supercon Technologies, Inc., a wholly-owned subsidiary of the Company, from 2009 to 2013. The Company’s Board and management are extremely grateful for Mr. van Ingen’s guidance and leadership over the years and extend their deepest condolences to his... Read more

Roche’s polatuzumab vedotin receives priority medicines scheme (PRIME) designation for treatment of the most common form of aggressive lymphoma

Basel, 30 June 2017 Roche’s polatuzumab vedotin receives priority medicines scheme (PRIME) designation for treatment of the most common form of aggressive lymphoma European Medicines Agency PRIME (PRIority MEdicines) status is granted to medicines that may offer a major therapeutic advantage over existing treatments, or benefit patients without treatment options First PRIME designation for a... Read more